Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children:

Julie Sommet1,2,3, Enora Le Roux1,2,4, Bérengère Koehl5,6

  • 1AP-HP, Hôpital Robert-Debré, Unité d'épidémiologie clinique, Inserm, CIC 1426, 48 bd Serurier, F-75019 Paris, France.

Insights

The method used to analyze blood pressure (BP) significantly impacts the prediction of sickle cell disease (SCD) severity in children. Different statistical approaches yield varying results for assessing BP

Area of Science:

  • Pediatric Hematology
  • Clinical Epidemiology
  • Biostatistics

Background:

  • Pediatric studies often explore the link between biological parameters (BP) and sickle cell disease (SCD) severity.
  • Existing research uses diverse methods for collecting and analyzing BP data in children with SCD.
  • This variability in methodology complicates the interpretation of prognostic results.

Purpose of the Study:

  • To assess how different BP collection and statistical analysis methods affect prognostic outcomes in pediatric SCD cohort studies.
  • To evaluate the association between BP and cerebral vasculopathy (CV) in a cohort of 375 children with SCD using various statistical approaches.

Main Methods:

  • Systematic identification of BP collection and statistical analysis methods in published SCD cohort studies.
  • Application of four distinct statistical methods (baseline, last known, mean, two-stage modeling) to a cohort of 375 children with SCD.
  • Evaluation of the association between BP and cerebral vasculopathy (CV) using these varied methods.

Main Results:

  • BP data were collected either once or multiple times during follow-up in 16 cohort studies.
  • The four statistical methods applied to the study cohort produced different results and interpretations regarding the BP-CV association.
  • The choice of statistical analysis method demonstrably influences the observed relationship between BP and CV.

Conclusions:

  • The prognostic value of biological parameters (BP) in pediatric SCD is contingent upon the statistical analysis method employed.
  • Standardizing or carefully considering statistical approaches is crucial for achieving valuable and reproducible conclusions in prognostic factor studies.
  • This highlights the need for methodological rigor in pediatric SCD research to ensure reliable prognostic assessments.
Abstract

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
36.7K
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
280
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
263
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
634